PDGFB and pancreatic endocrine carcinoma: To study the specific contribution of platelet-derived PDGFB to the tumor microenvironment (TME), pl-PDGFB KO mice were crossbred to the RIP1-Tag2 (RT2) model for pancreatic neuroendocrine carcinoma [12].